Home
Akouos

Akouos Market Share Analysis for November 2025

Our Mission: Healthy Hearing Available to All. We are a precision genetic medicine company focused on developing gene therapies with the potential to restore, improve and preserve high-acuity physiologic hearing for people worldwide who live with disabling hearing loss.

Health > Biotechnology and Pharmaceuticals

Domainakouos.com

Year Founded2016

Employees51 - 200

Annual Revenue$25M - $50M

Akouos

Akouos (including company regionals)

akouos.com

See more website traffic and engagement information

Akouos Revenue up to November 2025 is 25M - 50M

revenue generated by Akouos top domains

Akouos top domains revenue over 3 years

Revenue for Akouos top domains

akouos.com25M - 50M

See more with Sales Intelligence

Total visits to Akouos's top domains

Understand Akouos market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

akouos.com2.6K

See more with Sales Intelligence

Avg. visit duration in Akouos's top domains

Analyze Akouos engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

akouos.com00:02:09

See more with Sales Intelligence

Avg. pageviews on Akouos's top domains

See how Akouos keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

akouos.com2.40

See more with Sales Intelligence

Akouos top competitors by domain

Top similar sites in November 2025, ranked by their affinity

dewpointx.comCompany NameDewpoint Therapeutics, Inc.Employees51 - 200HQUnited States, Massachusetts, BostonAnnual revenue$10M - $15MTotal visits5.2KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Akouos

These are the website technologies, by industry, used by Akouos top domains

Conversion & Analytics (3)

Google Analytics

Widget (3)

Twemoji

Advertising (2)

DoubleClick

Mobile (2)

Meta Viewport

More Technologies

8

See all

News & Signals from Akouos

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAkouos, Inc. had issues with possible breaches of fiduciary duty and other violations of law on Oct 18th '22.Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Akouos, Inc. ("Akouos" or the "Company") (NASDAQ: AKUS ), in connection with the proposed tender offer for the Company by Eli Lilly and Company (NYSE: LLY ).

NewsLillyindia acquires Akouos, Inc. for $487M.Eli Lilly and Co will acquire genetic medicine developer Akouos Inc for about $487 million in cash as the drugmaker aims to bolster its arsenal of gene therapies that target a range of disabilities.

NewsAkouos, Inc. hired Aaron Tward as chief scientific officer on Mar 1st '22.Akouos, Inc. (NASDAQ: AKUS), a precision genetic medicine company dedicated to developing potential gene therapies for individuals living with disabling hearing loss worldwide, today announced the appointment of Aaron Tward, M.D., Ph.D., as chief scientific officer.